Home/Filings/4/0001179110-12-002570
4//SEC Filing

KACIAN DANIEL L 4

Accession 0001179110-12-002570

CIK 0000820237other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 5:59 PM ET

Size

13.2 KB

Accession

0001179110-12-002570

Insider Transaction Report

Form 4
Period: 2012-02-10
KACIAN DANIEL L
Exec. VP, Chief Scientist
Transactions
  • Exercise/Conversion

    Common Stock

    2012-02-10+1,86378,574 total
  • Tax Payment

    Common Stock

    2012-02-10$69.22/sh623$43,12477,951 total
  • Tax Payment

    Common Stock

    2012-02-10$69.22/sh258$17,85977,693 total
  • Award

    Performance Stock Rights

    2012-02-10+2974,997 total
    Exercise: $0.00From: 2012-02-10Exp: 2014-02-10Common Stock (297 underlying)
  • Exercise/Conversion

    Performance Stock Rights

    2012-02-101,8633,134 total
    Exercise: $0.00Exp: 2014-02-10Common Stock (1,863 underlying)
Footnotes (7)
  • [F1]The amount reported reflects shares of the Issuer's common stock issued to the Reporting Person pursuant to performance stock rights granted to the Reporting Person in February 2011.
  • [F2]The amount reported includes an aggregate of 180 shares of common stock acquired under the Gen-Probe Incorporated Employee Stock Purchase Plan since the Reporting Person last filed a Form 4 with the Securities and Exchange Commission.
  • [F3]Withholding of stock to satisfy tax withholding obligation upon vesting of shares issued to the Reporting Person as described herein.
  • [F4]Withholding of stock to satisfy tax withholding obligation upon vesting of shares previously issued to the Reporting Person.
  • [F5]Represents additional shares subject to the performance stock rights awarded to the Reporting Person in February 2012 based on actual achievement.
  • [F6]Remaining shares subject to the performance stock rights vest and may be issued to the Reporting Person in February 2013 and February 2014 based on the Issuer's adjusted relative stockholder return during the applicable performance periods.
  • [F7]The amount reported reflects the remaining target number of shares of Issuer common stock that may be issued to the Reporting Person based on the Issuer's adjusted relative stockholder return for the remaining performance periods. Based on actual achievement, the Reporting Person may receive between 0% and 200% of the remaining target number of shares of Issuer common stock reported herein.

Issuer

GEN PROBE INC

CIK 0000820237

Entity typeother

Related Parties

1
  • filerCIK 0001230317

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:59 PM ET
Size
13.2 KB